HLAA has received permission from the U.S. Food and Drug Administration (FDA) to host an Externally-Led Patient-Focused Drug Development Meeting (EL-PFDD) for People and Families Living with Sensorineural Hearing Loss on Tuesday, May 25, from 10 a.m.-3 p.m., U.S. ET. This is a YouTube Live virtual meeting, and all are welcome to attend. You can … Continue reading HLAA Receives Permission from the FDA to Host a Meeting on Sensorineural Hearing Loss on May 25